Cellectar BioSciences | S-3:特定交易註冊聲明
Cellectar BioSciences | DEFR14A:修正後委託徵集材料
Cellectar BioSciences | 8-K:重大事件
Cellectar BioSciences | 10-Q:季度報表
Cellectar BioSciences | DEFA14A:其他
Cellectar BioSciences | ARS:年度報告
Cellectar BioSciences | DEF 14A:股東委託書決議
Cellectar BioSciences | SC 13G/A:超過5%持股股東披露文件(修正)-Rosalind Advisors, Inc.(9.9%),Steven Salamon(9.9%)等
Cellectar BioSciences | 10-K/A:年度報表(修正版)
Cellectar BioSciences | 8-K:重大事件
Cellectar BioSciences | 10-K:年度報表
Cellectar BioSciences | SC 13G/A:超過5%持股股東披露文件(修正)-Rosalind Advisors, Inc.(9.9%),Steven Salamon(9.9%)等
Cellectar BioSciences | SC 13G:超過5%持股股東披露文件-Nantahala Capital Management, LLC(9.9%),Wilmot B. Harkey(9.9%)等
Cellectar BioSciences | SC 13G/A:超過5%持股股東披露文件(修正)-Lincoln Park Capital Fund, LLC(9.676%),Lincoln Park Capital, LLC(9.676%)等
Cellectar BioSciences | SC 13G/A:超過5%持股股東披露文件(修正)-Laurence W. Lytton(9.99%)
Cellectar BioSciences | SC 13G/A:超過5%持股股東披露文件(修正)-AIGH Capital Management, LLC(8.7%),Orin H(8.7%)
Cellectar BioSciences | 8-K:重大事件
Cellectar BioSciences | SC 13G:超過5%持股股東披露文件-ADAR1 Partners, LP(6.21%),ADAR1 Capital Management, LLC(6.21%)等
Cellectar BioSciences | 8-K:重大事件
Cellectar BioSciences | 8-K:重大事件
暫無數據